Organ-on-Chip Market to Experience Fastest Growth in North America & Asia-Pacific Region

1
Organ-on-Chip Market predicted to experience
noticeable growth in the future! Allied market
research

• Organ-on-Chip Market by Type (Heart-on-chip,
  Human-on-chip, Intestine-on-chip, Kidney-on-chip,
  Liver-on-chip, and Lung-on-chip) - Global
  Opportunity Analysis and Industry Forecast,
  2017-2023

2
Why Allied Market Research?
FREQUENTLY ASKED QUESTIONS?
INFALLIBLE METHODOLOGY To ensure high-level data
integrity, accurate analysis, and impeccable
forecasts ANALYST SUPPORT For complete
satisfaction CUSTOMIZATION On-demand
customization of scope of the report to exactly
meet your needs TARGETED MARKET VIEW Targeted
market view to provide pertinent information and
save time of readers

• Q1. Who are the leading market players active in
  the Organ-on-Chip Market?
• Q2. What are the current trends that will
  influence the market in the next few years?
• Q3. What are the driving factors, restraints, and
  opportunities in the market?
• Q4. What can be the challenges for the
  Organ-on-Chip Market in future?
• Q5. Does the Organ-on-Chip Market company is
  profiled in the report?

3
Overview

• The global organ-on-chip market was valued at 5
  million in 2016, and is projected to reach at
  170 million by 2023, growing at a CAGR of 63.2
  from 2017 to 2023. Heart-on-chip segment is
  anticipated to witness the highest growth rate
  during the forecast period.
• North America was the highest revenue contributor
  in the global market in 2016, as advancements in
  cell biology, microfabrication, and microfluidics
  have led to the development of OOCs. In addition,
  rise in demand for lung- and kidney-based organ
  culture devices is expected to boost the market
  growth. Asia-Pacific is anticipated to witness a
  significant growth rate during the forecast
  period, owing to increase in research activities.

4
Segments

• In terms of revenue, the global Organ-on-Chip
  Market is segmented on the basis of Type, and
  Regions.

By Type The global organ-on-chip market is
segmented on the basis of type and geography.
Based on type, the market is divided into
heart-on-chip, human-on-chip, intestine-on-chip,
kidney-on-chip, liver-on-chip, and lungs-on-chip.
Geographically, the organ-on-chip market is
analyzed across North America, Europe,
Asia-Pacific, and LAMEA. In 2016, the
lung-on-chip segment accounted for the highest
share in the market, while the heart-on-chip
segment is anticipated to witness the highest
growth rate from 2017 to 2023, owing to increase
in applications of organ-on-chip devices for the
cure of several cardiac diseases such as heart
failures.
5
Geography

• North America dominated the Organ-on-Chip Market.
  The market growth in North America is primarily a
  reflection of product innovations and launches
  resulting from technological advancements. The
  companies mostly adopted product launch,
  acquisition, and expansion as their key
  strategies to keep pace with the changing demands
  of consumers and strengthen their market position.

6
Key Market Players

• The key players operating in the global
  Organ-on-Chip Market are
• Emulate, Inc.
• AxoSim Technologies LLC
• CN Bio Innovations
• Hurel Corporation
• Ascendance Biotechnology, Inc.
• Insphero AG
• Mimetas B.V.
• Nortis Inc.
• Organovo Holdings, Inc.
• Tara Biosystems

7
Key Findings of the Organ-on-Chip Market

• An in-depth market analysis includes analysis of
  various regions, which is anticipated to provide
  a detailed understanding of the current trends to
  enable stakeholders formulate region-specific
  plans.
• A comprehensive analysis of factors that drive
  and restrain the growth of the global is
  provided.
• The projections in this report are made by
  analyzing the current trends and future market
  potential from 2021 to 2030, in terms of value.

Find out more at the Allied Market Report store
https//www.alliedmarketresearch.com/organ-on-chip
-market